SWK will retain 100% of any manufacturing-related revenues related to these two products. If Enteris’ third most advanced 505 (b) (2) product is out-licensed, SWK will receive 90% of all proceeds.

Conference Call Scheduled for Friday, May 16, 2025, at 09:00 a.m. CST Corporate Highlights First quarter 2025 GAAP net income was $4.5 million, compared with GAAP net income of $0.5 million for ...

SWK Funding has agreed to provide a $20 million loan to Massachusetts-based Cheetah Medical, a provider of fluid management devices. The capital will be used to pay down existing debt and invest ...

In December, SWK closed a $25.7M expansion of its existing credit facility with Eton, which now totals $30.0M. On funding, SWK received 289,736 warrants to purchase Eton stock at $5.32 per share.

Here are some of the largest recent moves: CAPITAL RESEARCH GLOBAL INVESTORS added 3,063,114 shares (+126.5%) to their portfolio in Q4 2024, for an estimated $245,937,423 BARROW HANLEY MEWHINNEY ...

Sold 500 shares of SWK today at 99.00, Total shares remaining long 1,000. SWK LONG ...

SWK is relatively focused on the U.S., where it generated 60% of its 2021 sales, while Europe, emerging markets, Canada and other regions accounted for 17%, 14%, 5% and 4%, respectively.